Literature DB >> 3561925

Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance.

W R Bezwoda, N Mansoor, R Dansey, J D Esser.   

Abstract

The conversion of 1 beta [3H] androstenedione to estrone in the presence of NADPH by breast cancer homogenates was assessed in tumors from 35 subjects together with estrogen and progesterone receptor concentration. Breast cancers from post menopausal women had significantly higher aromatase activity than those from premenopausal women. Although in many instances the local production of estrogens was sufficient to the capable of exerting a biologic effect, there was, however, no correlation with tumor estrogen or progesterone receptor content. Further studies of the biological significance of tumor aromatisation will depend on direct observation of tumor aromatase and response to suitable doses of aromatase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3561925     DOI: 10.1159/000226438

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.

Authors:  M Görlich; G Winterfeld; P Hauff; W Arnold; I Fichtner; H J Staab
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients.

Authors:  L M Berstein; A A Larionov; A Sh Kyshtoobaeva; K M Pozharisski; V F Semiglazov; O A Ivanova
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Androgen receptors, serum androgen levels and survival of breast cancer patients.

Authors:  M Langer; E Kubista; M Schemper; J Spona
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

4.  Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation.

Authors:  J M Esteban; Z Warsi; M Haniu; P Hall; J E Shively; S Chen
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

5.  Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial.

Authors:  Matthew J Ellis; William R Miller; Yu Tao; Dean B Evans; Hilary A Chaudri Ross; Yasuhiro Miki; Takashi Suzuki; Hironobu Sasano
Journal:  Breast Cancer Res Treat       Date:  2008-10-22       Impact factor: 4.872

6.  Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells.

Authors:  V M Macaulay; J E Nicholls; J Gledhill; M G Rowlands; M Dowsett; A Ashworth
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.